Smith & Nephew SNATS ROA 2006-2019 | SNN

Current and historical return on assets (ROA) values for Smith & Nephew SNATS (SNN) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Smith & Nephew SNATS ROA for the three months ending June 30, 2019 was 0.00%.
Smith & Nephew SNATS ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2014-12-31 $0.50B $7.31B 7.00%
2014-09-30 $0.50B $7.65B 7.41%
2014-06-30 $0.52B $7.74B 8.35%
2014-03-31 $0.56B $5.94B 9.89%
2013-12-31 $0.56B $5.82B 9.97%
2013-09-30 $0.54B $5.57B 9.69%
2013-06-30 $0.55B $5.45B 10.17%
2013-03-31 $0.71B $5.47B 13.60%
2012-12-31 $0.73B $5.64B 14.34%
2012-09-30 $0.73B $5.00B 14.96%
2012-06-30 $0.73B $4.81B 15.07%
2012-03-31 $0.59B $4.88B 12.13%
2011-12-31 $0.58B $4.75B 12.08%
2011-09-30 $0.62B $4.82B 12.96%
2011-06-30 $0.63B $4.91B 13.01%
2011-03-31 $0.61B $4.79B 12.90%
2010-12-31 $0.62B $4.73B 13.13%
2010-09-30 $0.56B $4.88B 12.09%
2010-06-30 $0.55B $4.58B 12.06%
2010-03-31 $0.53B $4.54B 11.69%
2009-12-31 $0.47B $4.57B 10.48%
2009-09-30 $0.46B $4.63B 10.22%
2009-06-30 $0.41B $4.52B 9.07%
2009-03-31 $0.39B $4.31B 8.64%
2008-12-31 $0.38B $4.51B 8.15%
2008-09-30 $0.36B $4.53B 7.87%
2008-06-30 $0.30B $4.71B 6.63%
2008-03-31 $0.31B $4.67B 6.99%
2007-12-31 $0.32B $4.45B 7.81%
2007-09-30 $0.36B $4.28B 9.49%
2007-06-30 $0.44B $4.23B 12.53%
2007-03-31 $0.42B $3.22B 13.24%
2006-12-31 $0.75B $3.23B 23.69%
2006-09-30 $0.70B $3.20B 22.12%
2006-06-30 $0.67B $3.16B 21.52%
2006-03-31 $0.67B $3.10B 21.59%
2005-12-31 $0.34B $3.19B 11.10%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $19.279B $4.904B
Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $151.583B 20.94
Abbott Laboratories (ABT) United States $151.168B 27.57
Stryker (SYK) United States $76.313B 25.66
Boston Scientific (BSX) United States $61.440B 29.00
Baxter (BAX) United States $42.463B 25.75
Essilor Luxottica (ESLOY) France $33.468B 0.00
Zimmer Biomet Holdings (ZBH) United States $30.550B 19.17
Terumo (TRUMY) Japan $27.062B 0.00
Lonza Group Ag (LZAGY) Switzerland $25.531B 0.00
Coloplast (CLPBY) Denmark $25.294B 39.03
ResMed (RMD) United States $21.653B 39.94
Sunny Optical Technology (SNPTF) China $19.151B 0.00
Insulet (PODD) United States $11.373B 541.06
Bio-Rad Laboratories (BIO) United States $11.201B 53.76
DiaSorin S.p.A (DSRLF) Italy $7.616B 0.00
William Demant Holdings (WILYY) Denmark $7.531B 0.00
Hill-Rom Holdings (HRC) United States $7.203B 21.24
Perrigo (PRGO) Ireland $7.117B 13.27
Canopy Growth (CGC) Canada $6.501B 0.00
Haemonetics (HAE) United States $6.146B 41.53
Shandong Weigao Medical Polymer (SHWGF) China $5.743B 0.00
GN STORE NORD (GNNDY) Denmark $5.276B 0.00
NuVasive (NUVA) United States $3.890B 30.64
ICU Medical (ICUI) United States $3.830B 24.97
Neogen (NEOG) United States $3.545B 59.33
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.165B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.121B 0.00
Quidel (QDEL) United States $2.954B 28.04
Aurora Cannabis (ACB) Canada $2.648B 0.00
National Vision Holdings (EYE) United States $2.432B 54.89
Agios Pharmaceuticals (AGIO) United States $2.411B 0.00
Cardiovascular Systems (CSII) United States $1.577B 0.00
InMode (INMD) Israel $1.516B 0.00
AtriCure (ATRC) United States $1.226B 0.00
Aphria (APHA) $1.187B 0.00
VAREX IMAGING (VREX) United States $1.162B 23.28
Phibro Animal Health (PAHC) United States $0.994B 18.61
NanoString Technologies (NSTG) United States $0.944B 0.00
Lantheus Holdings (LNTH) United States $0.802B 20.04
Eagle Pharmaceuticals (EGRX) United States $0.771B 29.55
TG Therapeutics (TGTX) United States $0.709B 0.00
Quanterix (QTRX) United States $0.705B 0.00
LeMaitre Vascular (LMAT) United States $0.698B 39.25
PetIQ (PETQ) United States $0.675B 16.46
Omeros (OMER) United States $0.655B 0.00
Cerus (CERS) United States $0.574B 0.00
Surmodics (SRDX) United States $0.570B 59.24
HEXO (HEXO) $0.537B 0.00
OraSure Technologies (OSUR) United States $0.492B 29.52
Owens & Minor (OMI) United States $0.474B 17.53
MacroGenics (MGNX) United States $0.474B 0.00
Organigram Holdings (OGI) Canada $0.405B 0.00
Utah Medical Products (UTMD) United States $0.396B 28.71
Meridian Bioscience (VIVO) United States $0.396B 13.62
BioLife Solutions (BLFS) United States $0.331B 134.92
Zynex (ZYXI) United States $0.329B 37.22
Bovie Medical (APYX) United States $0.275B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.269B 0.00
United Health Products (UEEC) United States $0.249B 0.00
Viemed Healthcare (VMD) United States $0.242B 25.52
Vapotherm (VAPO) United States $0.227B 0.00
Repro-Med Systems (KRMD) United States $0.195B 0.00
Liberty Health Sciences (LHSIF) Canada $0.192B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.164B 0.00
InfuSystems Holdings (INFU) United States $0.153B 773.00
Chimerix (CMRX) United States $0.151B 0.00
Female Health (VERU) United States $0.148B 0.00
Rockwell Medical (RMTI) United States $0.141B 0.00
Cytosorbents (CTSO) United States $0.128B 0.00
Fonar (FONR) United States $0.128B 9.03
MTech Acquisition (KERN) United States $0.114B 0.00
United-Guardian (UG) United States $0.091B 23.15
Oramed Pharmaceuticals (ORMP) United States $0.080B 0.00
Chembio Diagnostics (CEMI) United States $0.069B 0.00
Nephros (NEPH) United States $0.064B 0.00
Surface Oncology (SURF) United States $0.062B 0.00
MRI Interventions (MRIC) United States $0.061B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Trinity Biotech (TRIB) Ireland $0.024B 0.00
Senestech (SNES) United States $0.017B 0.00
GUARDION HEALTH (GHSI) United States $0.015B 0.00
Valeritas Holdings (VLRX) United States $0.013B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.012B 0.00
Myomo (MYO) United States $0.008B 0.00
Capricor Therapeutics (CAPR) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.005B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00